These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23583659)

  • 21. The Thyroid Hormone-target Gene Rhes a Novel Crossroad for Neurological and Psychiatric Disorders: New Insights from Animal Models.
    Napolitano F; D'Angelo L; de Girolamo P; Avallone L; de Lange P; Usiello A
    Neuroscience; 2018 Aug; 384():419-428. PubMed ID: 29857029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rhes, the Ras homolog enriched in striatum, is reduced under conditions of dopamine supersensitivity.
    Harrison LM; LaHoste GJ
    Neuroscience; 2006; 137(2):483-92. PubMed ID: 16352400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes.
    Lee JH; Tecedor L; Chen YH; Monteys AM; Sowada MJ; Thompson LM; Davidson BL
    Neuron; 2015 Jan; 85(2):303-15. PubMed ID: 25556834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global Rhes knockout in the Q175 Huntington's disease mouse model.
    Heikkinen T; Bragge T; Kuosmanen J; Parkkari T; Gustafsson S; Kwan M; Beltran J; Ghavami A; Subramaniam S; Shahani N; Ramírez-Jarquín UN; Park L; Muñoz-Sanjuán I; Marchionini DM
    PLoS One; 2021; 16(10):e0258486. PubMed ID: 34648564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coupling of D2R Short but not D2R Long receptor isoform to the Rho/ROCK signaling pathway renders striatal neurons vulnerable to mutant huntingtin.
    Galan-Rodriguez B; Martin E; Brouillet E; Déglon N; Betuing S; Caboche J
    Eur J Neurosci; 2017 Jan; 45(1):198-206. PubMed ID: 27717053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration.
    Dong X; Zong S; Witting A; Lindenberg KS; Kochanek S; Huang B
    J Gene Med; 2012 Jul; 14(7):468-81. PubMed ID: 22700462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons.
    Sciamanna G; Napolitano F; Pelosi B; Bonsi P; Vitucci D; Nuzzo T; Punzo D; Ghiglieri V; Ponterio G; Pasqualetti M; Pisani A; Usiello A
    Neurobiol Dis; 2015 Jun; 78():146-61. PubMed ID: 25818655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omi / HtrA2 is relevant to the selective vulnerability of striatal neurons in Huntington's disease.
    Inagaki R; Tagawa K; Qi ML; Enokido Y; Ito H; Tamura T; Shimizu S; Oyanagi K; Arai N; Kanazawa I; Wanker EE; Okazawa H
    Eur J Neurosci; 2008 Jul; 28(1):30-40. PubMed ID: 18662332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRIM37 is a primate-specific E3 ligase for Huntingtin and accounts for the striatal degeneration in Huntington's disease.
    Qin Y; Chen L; Zhu W; Song J; Lin J; Li Y; Zhang J; Song X; Xing T; Guo T; Duan X; Zhang Y; Ruan E; Wang Q; Li B; Yang W; Yin P; Yan XX; Li S; Li XJ; Yang S
    Sci Adv; 2024 May; 10(20):eadl2036. PubMed ID: 38758800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brain.
    Lim NK; Hung LW; Pang TY; Mclean CA; Liddell JR; Hilton JB; Li QX; White AR; Hannan AJ; Crouch PJ
    Hum Mol Genet; 2014 Aug; 23(15):4051-63. PubMed ID: 24634145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rhes travels from cell to cell and transports Huntington disease protein via TNT-like protrusion.
    Sharma M; Subramaniam S
    J Cell Biol; 2019 Jun; 218(6):1972-1993. PubMed ID: 31076452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curbing Rhes Actions: Mechanism-based Molecular Target for Huntington's Disease and Tauopathies.
    Subramaniam S; Boregowda S
    CNS Neurol Disord Drug Targets; 2024; 23(1):21-29. PubMed ID: 36959146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid hormone regulation of rhes, a novel Ras homolog gene expressed in the striatum.
    Vargiu P; Morte B; Manzano J; Perez J; de Abajo R; Gregor Sutcliffe J; Bernal J
    Brain Res Mol Brain Res; 2001 Oct; 94(1-2):1-8. PubMed ID: 11597759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ubiquitin-proteasome system alterations in a striatal cell model of Huntington's disease.
    Hunter JM; Lesort M; Johnson GV
    J Neurosci Res; 2007 Jun; 85(8):1774-88. PubMed ID: 17455294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation.
    Charvin D; Vanhoutte P; Pagès C; Borrelli E; Caboche J
    Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12218-23. PubMed ID: 16103364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease.
    Francelle L; Galvan L; Gaillard MC; Guillermier M; Houitte D; Bonvento G; Petit F; Jan C; Dufour N; Hantraye P; Elalouf JM; De Chaldée M; Déglon N; Brouillet E
    Hum Mol Genet; 2015 Mar; 24(6):1563-73. PubMed ID: 25398949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Huntington aggregates may not predict neuronal death in Huntington's disease.
    Kuemmerle S; Gutekunst CA; Klein AM; Li XJ; Li SH; Beal MF; Hersch SM; Ferrante RJ
    Ann Neurol; 1999 Dec; 46(6):842-9. PubMed ID: 10589536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons.
    Errico F; Santini E; Migliarini S; Borgkvist A; Centonze D; Nasti V; Carta M; De Chiara V; Prosperetti C; Spano D; Herve D; Pasqualetti M; Di Lauro R; Fisone G; Usiello A
    Mol Cell Neurosci; 2008 Feb; 37(2):335-45. PubMed ID: 18035555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rac1 Activity Is Modulated by Huntingtin and Dysregulated in Models of Huntington's Disease.
    Tousley A; Iuliano M; Weisman E; Sapp E; Zhang N; Vodicka P; Alexander J; Aviolat H; Gatune L; Reeves P; Li X; Khvorova A; Ellerby LM; Aronin N; DiFiglia M; Kegel-Gleason KB
    J Huntingtons Dis; 2019; 8(1):53-69. PubMed ID: 30594931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA.
    Wang YL; Liu W; Wada E; Murata M; Wada K; Kanazawa I
    Neurosci Res; 2005 Nov; 53(3):241-9. PubMed ID: 16095740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.